M. Tulinius

14.4k total citations · 1 hit paper
126 papers, 4.9k citations indexed

About

M. Tulinius is a scholar working on Molecular Biology, Clinical Biochemistry and Genetics. According to data from OpenAlex, M. Tulinius has authored 126 papers receiving a total of 4.9k indexed citations (citations by other indexed papers that have themselves been cited), including 114 papers in Molecular Biology, 45 papers in Clinical Biochemistry and 29 papers in Genetics. Recurrent topics in M. Tulinius's work include Mitochondrial Function and Pathology (56 papers), Metabolism and Genetic Disorders (45 papers) and Muscle Physiology and Disorders (41 papers). M. Tulinius is often cited by papers focused on Mitochondrial Function and Pathology (56 papers), Metabolism and Genetic Disorders (45 papers) and Muscle Physiology and Disorders (41 papers). M. Tulinius collaborates with scholars based in Sweden, United States and United Kingdom. M. Tulinius's co-authors include Anders Oldfors, Niklas Darín, Elisabeth Holme, Nils‐Göran Larsson, Anna‐Karin Kroksmark, B. Kristiansson, Ali‐Reza Moslemi, E. Holme, Eva Kimber and Anne‐Berit Ekström and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

M. Tulinius

122 papers receiving 4.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy

2011 518 citations M. Tulinius, Niklas Darín et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
M. Tulinius Sweden	42	4.0k	1.5k	1.0k	597	493	126	4.9k
Claudio Bruno Italy	37	3.3k 0.8×	865 0.6×	678 0.7×	483 0.8×	426 0.9×	146	4.6k
Lucía Morandi Italy	43	3.7k 0.9×	423 0.3×	835 0.8×	754 1.3×	359 0.7×	143	5.2k
Carlo Minetti Italy	50	5.4k 1.4×	571 0.4×	617 0.6×	805 1.3×	729 1.5×	190	7.5k
Morten Dunø Denmark	35	2.6k 0.7×	777 0.5×	281 0.3×	745 1.2×	650 1.3×	184	3.8k
Gabriella Silvestri Italy	35	3.5k 0.9×	1.4k 0.9×	261 0.3×	1.3k 2.2×	229 0.5×	126	4.4k
Thomas Voït Germany	40	3.5k 0.9×	297 0.2×	982 1.0×	527 0.9×	698 1.4×	136	5.3k
D. Gardner‐Medwin United Kingdom	33	2.2k 0.6×	374 0.2×	581 0.6×	544 0.9×	464 0.9×	111	3.4k
Adele D’Amico Italy	36	3.0k 0.8×	224 0.1×	1.3k 1.3×	550 0.9×	318 0.6×	168	4.2k
E. Bonilla United States	40	4.8k 1.2×	2.8k 1.8×	193 0.2×	771 1.3×	256 0.5×	76	5.4k
Brenda Wong United States	36	2.9k 0.7×	209 0.1×	1.1k 1.1×	346 0.6×	299 0.6×	142	4.2k

Countries citing papers authored by M. Tulinius

Since Specialization

Citations

This map shows the geographic impact of M. Tulinius's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Tulinius with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Tulinius more than expected).

Fields of papers citing papers by M. Tulinius

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M. Tulinius. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Tulinius. The network helps show where M. Tulinius may publish in the future.

Co-authorship network of co-authors of M. Tulinius

This figure shows the co-authorship network connecting the top 25 collaborators of M. Tulinius. A scholar is included among the top collaborators of M. Tulinius based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Tulinius. M. Tulinius is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kroksmark, Anna‐Karin, et al.. (2023). Low bone mineral density and reduced bone‐specific alkaline phosphatase in 5q spinal muscular atrophy type 2 and type 3: A 2‐year prospective study of bone health. Acta Paediatrica. 112(12). 2589–2600. 4 indexed citations

Mercuri, Eugenio, A. Nascimento Osorio, Francesco Muntoni, et al.. (2023). Safety and effectiveness of ataluren in patients with nonsense mutation DMD in the STRIDE Registry compared with the CINRG Duchenne Natural History Study (2015–2022): 2022 interim analysis. Journal of Neurology. 270(8). 3896–3913. 21 indexed citations

Vissing, John, Elsebet Østergaard, Laurence A. Bindoff, et al.. (2021). Phenotypic spectrum and clinical course of single large-scale mitochondrial DNA deletion disease in the paediatric population: a multicentre study. Journal of Medical Genetics. 60(1). 65–73. 11 indexed citations

Wahlgren, L., Anna‐Karin Kroksmark, M. Tulinius, & Kalliopi Sofou. (2021). One in five patients with Duchenne muscular dystrophy dies from other causes than cardiac or respiratory failure. European Journal of Epidemiology. 37(2). 147–156. 33 indexed citations

Desguerre, Isabelle, Francesco Muntoni, A. Nascimento Osorio, et al.. (2019). Effect of Ataluren on Age at Loss of Ambulation in Nonsense Mutation Duchenne Muscular Dystrophy: Observational Data from the STRIDE Registry (P1.6-067). Neurology. 92(15_supplement). 1 indexed citations

Roos, Sara, Kalliopi Sofou, Carola Hedberg‐Oldfors, et al.. (2018). Mitochondrial complex IV deficiency caused by a novel frameshift variant in MT-CO2 associated with myopathy and perturbed acylcarnitine profile. European Journal of Human Genetics. 27(2). 331–335. 17 indexed citations

McDonald, Craig M., K. Bushby, M. Tulinius, et al.. (2016). Ataluren: An Overview of Clinical Trial Results in Nonsense Mutation Duchenne Muscular Dystrophy (P3.162). Neurology. 86(16_supplement). 2 indexed citations

Sofou, Kalliopi, I.F.M. de Coo, Pirjo Isohanni, et al.. (2014). A multicenter study on Leigh syndrome: disease course and predictors of survival. Orphanet Journal of Rare Diseases. 9(1). 52–52. 161 indexed citations

Sofou, Kalliopi, et al.. (2013). MRI of the brain in childhood-onset mitochondrial disorders with central nervous system involvement. Mitochondrion. 13(4). 364–371. 36 indexed citations

10.

Ferlini, Alessandra, M. Tulinius, E. Niks, et al.. (2013). T.I.2 Exon skipping and PRO044 in Duchenne muscular dystrophy: Extending the program. Neuromuscular Disorders. 23(9-10). 847–847. 2 indexed citations

11.

Strömberg, Anneli, Niklas Darín, Anna‐Karin Kroksmark, & M. Tulinius. (2012). S.P.31 What was the age and cause of death in patients with Duchenne muscular dystrophy in Sweden during 2000–2010?. Neuromuscular Disorders. 22(9-10). 880–881. 12 indexed citations

12.

Ekström, Anne‐Berit, et al.. (2008). Autism spectrum conditons in myotonic dystrophy type 1: A study on 57 individuals with congenital and childhood forms. American Journal of Medical Genetics Part B Neuropsychiatric Genetics. 147B(6). 918–926. 95 indexed citations

13.

Darín, Niklas, Eva Lagberg Arkblad, Anna‐Karin Kroksmark, et al.. (2007). G.P.2.11 Spinal muscular atrophy. The mutational spectra in children from Western Sweden. Neuromuscular Disorders. 17(9-10). 779–779.

14.

Darín, Niklas, et al.. (2007). M.P.1.12 Progressive encephalopathy and complex I deficiency associated with novel mutations in MTND1. Neuromuscular Disorders. 17(9-10). 771–771. 4 indexed citations

15.

Tajsharghi, Homa, Niklas Darín, M. Tulinius, & Anders Oldfors. (2005). Early onset myopathy with a novel mutation in the Selenoprotein N gene (SEPN1). Neuromuscular Disorders. 15(4). 299–302. 31 indexed citations

16.

Oldfors, Anders & M. Tulinius. (2003). Mitochondrial Encephalomyopathies. Journal of Neuropathology & Experimental Neurology. 62(3). 217–227. 32 indexed citations

17.

Moslemi, Ali‐Reza, M. Tulinius, Elisabeth Holme, & Anders Oldfors. (1998). Threshold expression of the tRNALys A8344G mutation in single muscle fibres. Neuromuscular Disorders. 8(5). 345–349. 38 indexed citations

18.

Holme, Elisabeth, et al.. (1995). Inheritance and expression of mitochondrial DNA point mutations. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1271(1). 249–252. 16 indexed citations

19.

Houshmand, Massoud, Nils‐Göran Larsson, Elisabeth Holme, et al.. (1994). Automatic sequencing of mitochondrial tRNA genes in patients with mitochondrial encephalomyopathy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1226(1). 49–55. 42 indexed citations

20.

Oldfors, Anders, et al.. (1989). Cytochromec oxidase deficiency in infancy. Acta Neuropathologica. 77(3). 267–275. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact